Javascript is not activated in your browser. This website needs javascript activated to work properly.

Total, caffeinated and decaffeinated coffee and tea intake and gastric cancer risk : Results from the EPIC cohort study

  • Harinakshi Sanikini
  • Vincent K. Dik
  • Peter D. Siersema
  • Nirmala Bhoo-Pathy
  • Cuno S P M Uiterwaal
  • Petra H M Peeters
  • Carlos A. González
  • Raul Zamora-Ros
  • Kim Overvad
  • Anne Tjønneland
  • Nina Roswall
  • Marie Christine Boutron-Ruault
  • Guy Fagherazzi
  • Antoine Racine
  • Tilman Kühn
  • Verena Katzke
  • Heiner Boeing
  • Antonia Trichopoulou
  • Dimitrios Trichopoulos
  • Pagona Lagiou
  • Domenico Palli
  • Sara Grioni
  • Paolo Vineis
  • Rosario Tumino
  • Salvatore Panico
  • Elisabete Weiderpass
  • Guri Skeie
  • Tonje Braaten
  • José Maŕa Huerta
  • Emilio Sánchez-Cantalejo
  • Aurelio Barricarte
  • Emily Sonestedt
  • Peter Wallstrom
  • Lena Maria Nilsson
  • Ingegerd Johansson
  • Kathryn E. Bradbury
  • Kay Tee Khaw
  • Nick Wareham
  • Inge Huybrechts
  • Heinz Freisling
  • Amanda J. Cross
  • Elio Riboli
  • H. B. Bueno-de-Mesquita
Publishing year: 2015-03-15
Language: English
Pages: 720-730
Publication/Series: International Journal of Cancer
Volume: 136
Issue: 6
Document type: Journal article
Publisher: John Wiley and Sons Inc.

Abstract english

Prospective studies examining the association between coffee and tea consumption and gastric cancer risk have shown inconsistent results. We investigated the association between coffee (total, caffeinated and decaffeinated) and tea consumption and the risk of gastric cancer by anatomical site and histological type in the European Prospective Investigation into Cancer and Nutrition study. Coffee and tea consumption were assessed by dietary questionnaires at baseline. Adjusted hazard ratios (HRs) were calculated using Cox regression models. During 11.6 years of follow up, 683 gastric adenocarcinoma cases were identified among 477,312 participants. We found no significant association between overall gastric cancer risk and consumption of total coffee (HR 1.09, 95%-confidence intervals [CI]: 0.84-1.43; quartile 4 vs. non/quartile 1), caffeinated coffee (HR 1.14, 95%-CI: 0.82-1.59; quartile 4 vs. non/quartile 1), decaffeinated coffee (HR 1.07, 95%-CI: 0.75-1.53; tertile 3 vs. non/tertile 1) and tea (HR 0.81, 95%-CI: 0.59-1.09; quartile 4 vs. non/quartile 1). When stratified by anatomical site, we observed a significant positive association between gastric cardia cancer risk and total coffee consumption per increment of 100 mL/day (HR 1.06, 95%-CI: 1.03-1.11). Similarly, a significant positive association was observed between gastric cardia cancer risk and caffeinated coffee consumption (HR 1.98, 95%-CI: 1.16-3.36, p-trend=0.06; quartile 3 vs. non/quartile 1) and per increment of 100 mL/day (HR 1.09, 95%-CI: 1.04-1.14). In conclusion, consumption of total, caffeinated and decaffeinated coffee and tea is not associated with overall gastric cancer risk. However, total and caffeinated coffee consumption may be associated with an increased risk of gastric cardia cancer. Further prospective studies are needed to rule out chance or confounding.


  • Cancer and Oncology
  • Caffeinated coffee
  • Coffee
  • Decaffeinated coffee
  • European prospective investigation into cancer and nutrition
  • Gastric cancer
  • Tea


  • Nutrition Epidemiology
  • ISSN: 0020-7136
Emily Sonestedt
E-mail: emily [dot] sonestedt [at] med [dot] lu [dot] se

Associate senior lecturer

Nutrition Epidemiology

+46 40 39 13 25

+46 73 700 71 45


Jan Waldenströms gata 35, CRC 60:13, Malmö


Crafoords vetenskapslunch

Kan våra gener göra oss tjocka?

Tyngre träningssnack


Lund University Diabetes Centre, CRC, SUS Malmö, Jan Waldenströms gata 35, House 91:12. SE-214 28 Malmö. Telephone: +46 40 39 10 00